Skip to main content
. 2022 Oct 8;30(12):1736–1747. doi: 10.1016/j.jsps.2022.10.002

Fig. 3.

Fig. 3

Monoclonal antibodies and their targets. (A) Monoclonal antibodies in the prime line treatment (B) Monoclonal antibodies with possible targets. This figure was created with BioRender.com, Bio Render, Canada.